Simplex Trading’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$521 Buy
745
+142
+24% +$151 ﹤0.01% 8949
2026
Q1
$982 Sell
603
-2,572
-81% -$4.39K ﹤0.01% 8608
2025
Q4
$5.65K Buy
3,175
+2,713
+587% +$5.66K ﹤0.01% 7364
2025
Q3
$1K Buy
+462
New +$1.12K ﹤0.01% 8848
2024
Q2
Sell
-110
Closed -$258 9496
2024
Q1
$0 Buy
+110
New +$297 ﹤0.01% 9539
2023
Q4
Sell
-1,782
Closed -$5.13K 9488
2023
Q3
$5K Buy
+1,782
New +$5.69K ﹤0.01% 7672
2023
Q2
Sell
-56
Closed -$89 9610
2023
Q1
$0 Hold
56
﹤0.01% 9785
2022
Q4
$0 Hold
56
﹤0.01% 10013
2022
Q3
$0 Sell
56
-3
-5% -$5 ﹤0.01% 10583
2022
Q2
$0 Sell
59
-200
-77% -$474 ﹤0.01% 10716
2022
Q1
$0 Buy
+259
New +$718 ﹤0.01% 11088

Other funds holding NSPR

Simplex Trading's NSPR Position: Q2 2026 in Review

Simplex Trading increased its InspireMD (NSPR) stake by 24% in Q2 2026, buying an estimated $151 and bringing the position to 745 shares worth $521. The position accounts for ﹤0.01% of the portfolio, ranked #8949.

Simplex Trading first reported a position in NSPR in Q1 2022 and has held it in 11 quarters since. The position peaked at $5.65K in Q4 2025. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

  • Simplex Trading held 745 shares of InspireMD worth $521 as of Q2 2026.
  • Simplex Trading bought 142 InspireMD shares in Q2 2026, an estimated $151.
  • InspireMD made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8949 holding.
  • Simplex Trading first reported a position in InspireMD in Q1 2022 and has held it in 11 quarters since.
  • Simplex Trading's InspireMD position peaked at $5.65K in Q4 2025.
  • 37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.